|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Emergency contraception provision in the UK. |
| PLANNED PARENTHOOD IN EUROPE. 1995 Aug;24(2):20-2. |
| In the UK, 1/3 of births are unplanned despite the wide availability of free contraception. Therefore, the Family |
| Planning (FP) Association has been reviewing the provision of emergency contraception (EC). The IUD and |
| hormonal formulations have long been available for EC use, and about 400,000 women in the UK use EC each year, |
| with most of them choosing the hormonal pill regimen. This entails 2 doses of 100 mcg estrogen and 500 mcg |
| progestogen, with the 1st dose taken within 72 hours of unprotected intercourse and the 2nd dose taken exactly 12 |
| hours later. The IUD for EC should be inserted within 5 days of unprotected intercourse. Most women obtain EC |
| from general practitioners (GPs) or from FP clinics. The availability of EC is not widely publicized, however, and |
| women may have difficulty getting an appointment soon enough. Although many women have heard of EC, they lack |
| detailed knowledge of how it works, the time limits, and how to obtain it. Health professionals also require further |
| education about the use of this method of contraception. The EC guidelines for doctors were recently updated, |
| therefore, and a public information campaign about EC was launched that included the distribution of information |
| packs to GPs, FP clinics, pharmacies, and other National Health Service contacts. The consumer phase of the |
| campaign included radio and magazine advertisements and was covered widely in the media. Access to EC may |
| improve after the campaign, but the biggest impact on access would be to change the prescribing status to "over-the- |
| counter." This possibility is, therefore, being explored as an alternative to (not a replacement of) the free provision of |
| service by GPs or FP clinics. While service delivery is being explored, research is progressing into the use of |
| mifepristone as an EC with fewer side effects than the current hormonal regimen. (PubHealth.info Document ID: |
| PubHealth.info NOTE: The author(s) of this article titled, "Emergency contraception provision in the UK.", is(are) |
| Pappenheim K. The source of this article is "PLANNED PARENTHOOD IN EUROPE. 1995 Aug;24(2):20-2.". This |
| article was published in 1995 in English language(s). (PubHealth.info® Document ID: CONT2T 2579-06. All rights |
| reserved with PubHealth.info) PIN: 7579 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |